Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia
Clinical trial NCT01727232 · COMPLETED
Trial details
- NCT number
- NCT01727232
- Sponsor
- Henri Mondor University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2007-01-01
- Primary completion
- 2012-06-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.